EP4233846
PHARMACEUTICAL FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.6.2016EP published:
4.12.2024EP application number:
23162978.3
EPO information:
European Patent Register
Max expiry date:
28.6.2036
Title in English:
PHARMACEUTICAL FORMULATIONSLanguage of the patent:
English
Timeline
Today
29.6.2016EP application
4.12.2024EP Publication
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
KOZIARA, Joanna, M.Address:
Foster City, 94404, US
Name:
MCCALLISTER, ScottAddress:
Foster City, 94404, US
Priority
Number:
201562187113 PDate:
30.6.2015Country:
US
Number:
201662298373 PDate:
22.2.2016Country:
US
Number:
201662301429 PDate:
29.2.2016Country:
US
Number:
201662317286 PDate:
1.4.2016Country:
US
Classification
Categories:
A61K 9/20, A61K 9/24, A61K 31/513, A61K 31/675, A61K 9/00, A61K 9/28, A61P 31/18, A61P 43/00